Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Alzheimer's Drug Discovery Foundation Statement on FDA Approval of Aducanumab

PR Newswire June 7, 2021

CVS Health Completes Rollout of Time Delay Safes in All of Its Georgia Pharmacies

PR Newswire June 7, 2021

Synaptogenix Responds to FDA Approval of Aducanumab

PR Newswire June 7, 2021

CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia (CLL)

PR Newswire June 7, 2021

PDI Appoints Firas Abulaban as Vice President of Quality

PR Newswire June 7, 2021

NACDD Publishes FY 2022 Chronic Disease Appropriations Fact Sheets

PR Newswire June 7, 2021

Hill Physicians Medical Group Reports Strong Operating Performance in 2020

PR Newswire June 7, 2021

TrialJectory Survey Reveals 66 Percent of Cancer Patients Desire Greater Involvement in Treatment Decisions as a Result of COVID-19

PR Newswire June 7, 2021

Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care

PR Newswire June 7, 2021

BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June

Canada NewsWire June 7, 2021

Identification of an internalizing cancer target for novel antibody drug conjugate by A&G Pharmaceutical and Precision Antibody researchers.

PR Newswire June 7, 2021

ALKM - Alkame Announces First PPE Shipments In Fulfillment Of $1 Million Sales Contract

PR Newswire June 7, 2021

ObvioHealth announces a groundbreaking partnership with Dedalus Group to unite real world & clinical trial data

PR Newswire June 7, 2021

Swift Biosciences launches Swift 2S(TM) Turbo v2 for metagenomic research

PR Newswire June 7, 2021

Local Mental Health Organization Goes National to Fill Gaps in Care Across the Country

PR Newswire June 7, 2021

Company Set to Transform Cancer Patients' Lives Pitches for Funding on New Business Series Unicorn Hunters

PR Newswire June 7, 2021

Exero Medical announces its first in human data selected for presentation at "The Next Big Thing" session at SAGES 2021 annual meeting

PR Newswire June 7, 2021

HistoSonics Announces First Patient Treated in European Clinical Trial

PR Newswire June 7, 2021

Linnaeus Therapeutics Announces Presentation of Positive Phase 1 Clinical Data of LNS8801 at 2021 ASCO Annual Meeting

PR Newswire June 7, 2021

FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy

PR Newswire June 7, 2021